A clinical trial to compare the pain sparing effects of dexamethasone and clonidine in patients undergoing shoulder surgery.
Not Applicable
Completed
- Conditions
- Health Condition 1: M958- Other specified acquired deformities of musculoskeletal systemHealth Condition 2: null- Patients fit for shoulder surgeries
- Registration Number
- CTRI/2017/02/007852
- Lead Sponsor
- Department of Anaesthesia and Intensive care
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
American Society of Anesthesiologists (ASA) physical status I-II
Age 18-65 years
BMI â?? 18-30 kg/m2 of either sex
Arthroscopic shoulder surgery, such as rotator cuff injury repair, recurrent shoulder dislocations, superior labrum anterior and posterior (SLAP lesion), acromioplasty, labral cyst removal
Exclusion Criteria
Patient refusing to give informed consent
History of relevant drug allergy
History of psychiatric illness, substance abuse
Severe cardiovascular, respiratory, metabolic or neurological disease
Pregnancy and lactation
Coagulopathy
Contralateral phrenic nerve dysfunction
Infection at planned injection site
Patients receiving α2 agonists for hypertensive disorders
Patients on steroids
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of postoperative analgesia.Timepoint: Duration of postoperative analgesia, as measured (in min) from the achievement of adequate sensory block till the first bolus of 0.2% ropivacaine by PCRA.
- Secondary Outcome Measures
Name Time Method Measures pain ratings over 48 hour on 0-100 VAS, total postoperative analgesic consumption, patient satisfaction, and adverse effects.Timepoint: Measures pain ratings over 24 h on 0-100 VAS, total postoperative analgesic consumption, patient satisfaction, and adverse effects.